Speakers | RNA Leaders

Marc Abrams Senior Vice President, Discovery Research, Dicerna Pharmaceuticals

Marc Abrams

Senior Vice President, Discovery Research,

Dicerna Pharmaceuticals

Shalini Andersson, Chief Scientist, New Therapeutic Modalities and Head of Oligonucleotide Discovery, AstraZeneca

Shalini Andersson

Chief Scientist, New Therapeutic Modalities & Head of Oligonucleotide Discovery

AstraZeneca

Alexandra Bause, Co-Founder, Investment Director & Head of VentureLabs, Apollo Health Ventures

Alexandra Bause

Co-Founder, Investment Director & Head of VentureLabs

Apollo Health Ventures

Marcel Blommers, CSO, Saverna Therapeutics

Marcel Blommers

CSO

Saverna Therapeutics

Siham Ceballos, Founder and Managing Partner, Bioartemis

Siham Ceballos

Founder and Managing Partner

Bioartemis

Sudha Chivukula, Head of RNA Technology, Research & External Innovation, Sanofi Pasteur

Sudha Chivukula

Head of RNA Technology, Research & External Innovation

Sanofi Pasteur

Jason Coleman

Jason Coleman

Clinical Application Scientist Lead

Precision Nanosystems

Alexandre Di Paolo Business Development Senior Manager at Trilink Biotechnologies

Alexandre Di Paolo

Business Development Senior Manager

Trilink Biotechnologies

Denis Drygin, CSO, Regulus Therapeutics

Denis Drygin

CSO

Regulus Therapeutics

Yaniv Erlich, CEO, Eleven Therapeutics

Yaniv Erlich

CEO

Eleven Therapeutics

Douglas Fambrough, CEO, Dicerna Pharmaceuticals

Douglas Fambrough

CEO

Dicerna Pharmaceuticals

Malgorzata Gonciarz, Associate Vice President, Genetic Medicine, Eli Lilly

Malgorzata Gonciarz

Associate Vice President, Genetic Medicine

Eli Lilly

Tamar Grossmanm Global Head of RNA and Targeted Therapeutics, Janssen

Tamar Grossman

Global Head of RNA and Targeted Therapeutics

Janssen

Nagy Habib, Founder and Head of R&D, MiNA Therapeutics

Nagy Habib

Founder and Head of R&D

MiNA Therapeutics

Bill Haney, CEO & Chairman, Skyhawk Therapeutics

Bill Haney

CEO & Chairman

Skyhawk Therapeutics

Lorna Harries, Co-Founder and CSO, Senisca

Lorna Harries

Co-Founder and CSO

Senisca

Philipp Heller, Projektmanager Innovation, Evonik

Philipp Heller

Projektmanager Innovation

Evonik

Aimee Jackson, CSO, Atalanta Therapeutics

Aimee Jackson

CSO

Atalanta Therapeutics

Anastasiia Kamenska, Director, Corporate Strategy, Novartis

Anastasiia Kamenska

Director, Corporate Strategy

Novartis

Malin Lemurell, Executive Director and Head of Medicinal Chemistry Early CVRM, Biopharmaceuticals R&D, Astra Zeneca

Malin Lemurell

Executive Director and Head of Medicinal Chemistry Early CVRM

Biopharmaceuticals R&D, Astra Zeneca

Tim Luker, VP Venture Science, Corporate BD, Eli Lilly

Tim Luker

Vice President, Venture Science, Corp BD

Eli Lilly

Prof. Helen McCarthy, CEO, pHion Therapeutics

Helen McCarthy

CEO

pHion Therapeutics

Kathleen McCarthy, Co-Founder & Chief Scientific Officer, Skyhawk Therapeutics

Kathleen McCarthy

Co-Founder & Chief Scientific Officer

Skyhawk Therapeutics

Angele Maki, SVP, Business Development, ReCode Therapeutics

Angele Maki

SVP & Head of Business Development

ReCode Therapeutics

Melissa Moore, CSO, Moderna

Melissa Moore

CSO

Moderna

Johannes Muehl Senior Vice President, Finance, Exopharm

Johannes Muhl

Senior Vice President

Finance, Exopharm

Huw Nash, COO and CBO, Stoke Therapeutics-1

Huw Nash

COO and CBO

Stoke Therapeutics

Darach Neeson, COO, pHion Therapeutics

Darach Neeson

COO

pHion Therapeutics

Samir Ounzain, CEO and Scientific Co-Founder, HAYA Therapeutics

Samir Ounzain

CEO and Scientific Co-Founder

HAYA Therapeutics

Lykke Pedersen, Head of RNA Therapeutics, Abzu

Lykke Pedersen

Head of RNA Therapeutics

Abzu

Sylke Poehling, Senior Vice President and Global Head, Therapeutic Modalities, Roche

Sylke Poehling

Senior Vice President and Global Head, Therapeutic Modalities

Roche

Martin Rabel Field Application Scientist, Precision Nanosystems

Martin Rabel

Field Application Scientist

Precision Nanosystems

Umberto Romeo, Head of R&D, Corden Pharma GmbH

Umberto Romeo

Head of R&D

Corden Pharma GmbH

Kai Rossen, Chief Scientific Officer, EUROAPI

Kai Rossen

Chief Scientific Officer

EUROAPI

Branden Ryu,CEO, Biorchestra

Branden Ryu

CEO

Biorchestra

Suzanne Saffie-Siebert CEO at SiSaf

Suzanne Saffie-Siebert

CEO

SiSaf

Bernard Sagaert COO and Senior VP of Manufacturing, eTheRNA Immunotherapies

Bernard Sagaert

COO and Senior VP of Manufacturing

eTheRNA Immunotherapies

Laura Sepp-Lorenzino, CSO, Intellia Therapeutics

Laura Sepp-Lorenzino

CSO

Intellia Therapeutics

David Slack, CEO, Cend Therapeutics

David Slack

CEO

Cend Therapeutics

Peter Smith, Co-Founder, President and CEO, Remix Therapeutics

Peter Smith

Co-Founder, President and CEO

Remix Therapeutics

Brad Sorenson, Founder and CEO, Providence

Brad Sorenson

Founder and CEO

Providence Therapeutics

Thorsten Stafforst, Interfaculty Institute of Biochemistry, Eberhard Karls Universität Tübingen-1

Thorsten Stafforst

Interfaculty Institute of Biochemistry

Eberhard Karls Universität Tübingen

Dietrich Stephan

Dietrich Stephan

Founder and CEO

Neubase Therapeutics

Katarina Stenklo, Commercial Activation and End to End Solutions Leader, Cytiva

Katarina Stenklo

Commercial Activation and End to End Solutions Leader

Cytiva

Howard Stern, CSO, Korro Bio

Howard Stern

CSO

Korro Bio

Scott Taylor, Associate Director, Alliance Management, Trilink BioTechnologies

Scott Taylor

Associate Director, Alliance Management

Trilink BioTechnologies

Hans-Peter Vornlocher Managing Director Research Axolabs

Hans-Peter Vornlocher

Managing Director Research

Axolabs

Nathaniel Wang, CEO, Replicate Bioscience

Nathaniel Wang

CEO

Replicate Bioscience

Marie Wikstrom Lindholm, SVP and Head of Molecular Design, Silence Therapeutics

Marie Wikstrom Lindholm

SVP and Head of Molecular Design

Silence Therapeutics

Dominik Witzigmann,CEO & Co-Founder NanoVation Therapeutics-1

Dominik Witzigmann

CEO & Co-Founder

NanoVation Therapeutics

Matthew Wood, Professor of Neuroscience and Deputy Head, Medical Sciences Division, University of Oxford

Matthew Wood

Professor of Neuroscience and Deputy Head, Medical Sciences Division

University of Oxford

Klaas Zuideveld CEO, Versameb

Klaas Zuideveld

CEO

Versameb